Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

IMW 2019

Highlights

View all
1:40
Key topics from IMW 2019
Maria Victoria-Mateos • 12 Sep 2019
1:57
Paul Richardson’s angiopathy highlights
Paul Richardson • 13 Sep 2019

Expert Discussions

View all
10:42
Highlights from IMW 2019 Part I
Francesca Gay et al. • 25 Sep 2019
11:36
An MRD discussion: when, who and how
Faith Davies et al. • 14 Sep 2019

MRD

View all
1:22
NGS or flow-based MRD in myeloma? A need for consistency
Bruno Paiva • 12 Sep 2019
1:32
MRD in myeloma: an important surrogate for PFS
Bruno Paiva • 12 Sep 2019

Transplantation

View all
5:24
The role of transplantation in the treatment of multiple myeloma
David Siegel • 13 Sep 2019
1:55
MM: when is allogeneic transplant is the right answer?
Amrita Krishnan • 13 Sep 2019

Amyloidosis

View all
1:58
Implications of IMW 2019 on nursing practices
Tanya Burton • 14 Sep 2019
3:00
MRD as a prognostic tool in amyloidosis
Surbhi Sidana • 15 Sep 2019

Waldenström’s

View all
3:23
Progression risk stratification of asymptomatic WM
Romanos Sklavenitis-Pistofidis • 14 Sep 2019
2:13
Founding precision therapy for 1q-amplified multiple myeloma
Romanos Sklavenitis-Pistofidis • 14 Sep 2019
The content of VJHemOnc is intended for healthcare professionals